NCT00560950View on ClinicalTrials.gov

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

PHASE3CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Pneumococcal Infection
Interventions
BIOLOGICAL

pneumococcal 23v polysaccharide vaccine

Duration of Treatment: Single vaccination on Day 1

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00560950 - Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007) | Biotech Hunter | Biotech Hunter